Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays

被引:51
作者
Flanagan, KL [1 ]
Lee, EAM
Gravenor, MB
Reece, WHH
Urban, BC
Doherty, T
Bojang, KA
Pinder, M
Hill, AVS
Plebanski, M
机构
[1] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[2] MRC Labs, Malaria Lab, Fajara, Gambia
[3] Austin & Repatriat Med Ctr, Austin Res Inst, Vaccine & Infect Dis Unit, Melbourne, Vic, Australia
关键词
D O I
10.4049/jimmunol.167.8.4729
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural immunity to malaria Is characterized by low level CD4 T cell reactivity detected by either lymphoproliferation or IFN-gamma secretion. Here we show a doubling in the detection rate of responders to the carboxyl terminus of circumsporozoite protein (CS) of Plasmodium falciparum by employing three T cell assays simultaneously: rapid IFN-T secretion (ex vivo ELISPOT), IFN-gamma secretion after reactivation of memory T cells and expansion in vitro (cultured ELISPOT), and lymphoproliferation. Remarkably, for no individual peptide did a positive response for one T cell effector function correlate with any other. Thus these CS epitopes elicited unique T cell response patterns in malaria-exposed donors. Novel or important epitope responses may therefore be missed if only one T cell assay is employed. A borderline correlation was found between anti-CS Ab levels and proliferative responses, but no correlation was found with ex vivo or cultured IFN-gamma responses. This suggested that the proliferating population, but not the IFN-gamma -secreting cells, contained cells that provide help for Ab production. The data suggest that natural immunity to malaria is a complex function of T cell subgroups with different effector functions and has important implications for future studies of natural T cell immunity.
引用
收藏
页码:4729 / 4737
页数:9
相关论文
共 81 条
  • [1] IDENTIFICATION OF CONSERVED ANTIGENIC COMPONENTS FOR A CYTOTOXIC T-LYMPHOCYTE-INDUCING VACCINE AGAINST MALARIA
    AIDOO, M
    LALVANI, A
    ALLSOPP, CEM
    PLEBANSKI, M
    MEISNER, SJ
    KRAUSA, P
    BROWNING, M
    MORRISJONES, S
    GOTCH, F
    FIDOCK, DA
    TAKIGUCHI, M
    ROBSON, KJH
    GREENWOOD, BM
    DRUILHE, P
    WHITTLE, HC
    HILL, AVS
    [J]. LANCET, 1995, 345 (8956) : 1003 - 1007
  • [2] High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein
    Alloueche, A
    Silveira, H
    Conway, DJ
    Bojang, K
    Doherty, T
    Cohen, J
    Pinder, M
    Greenwood, BM
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 106 (02) : 273 - 282
  • [3] BALLOU WR, 1987, LANCET, V1, P1277
  • [4] THE CIRCUMSPOROZOITE PROTEIN GENE FROM NF54, A PLASMODIUM-FALCIPARUM ISOLATE USED IN MALARIA VACCINE TRIALS
    CASPERS, P
    GENTZ, R
    MATILE, H
    PINK, JR
    SINIGAGLIA, F
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1989, 35 (02) : 185 - 190
  • [5] THE BASOLATERAL DOMAIN OF THE HEPATOCYTE PLASMA-MEMBRANE BEARS RECEPTORS FOR THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM SPOROZOITES
    CERAMI, C
    FREVERT, U
    SINNIS, P
    TAKACS, B
    CLAVIJO, P
    SANTOS, MJ
    NUSSENZWEIG, V
    [J]. CELL, 1992, 70 (06) : 1021 - 1033
  • [6] PLASMODIUM-YOELII - 17-KDA HEPATIC AND ERYTHROCYTIC STAGE PROTEIN IS THE TARGET OF AN INHIBITORY MONOCLONAL-ANTIBODY
    CHAROENVIT, Y
    MELLOUK, S
    SEDEGAH, M
    TOYOSHIMA, T
    LEEF, MF
    DELAVEGA, P
    BEAUDOIN, RL
    AIKAWA, M
    FALLARME, V
    HOFFMAN, SL
    [J]. EXPERIMENTAL PARASITOLOGY, 1995, 80 (03) : 419 - 429
  • [7] CHEN DH, 1977, J IMMUNOL, V118, P1322
  • [8] IMMUNIZATION OF MAN AGAINST SPOROZITE-INDUCED FALCIPARUM MALARIA
    CLYDE, DF
    MOST, H
    MCCARTHY, VC
    VANDERBERG, JP
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1973, 266 (03) : 169 - 177
  • [9] SPOROZOITES OF MAMMALIAN MALARIA - ATTACHMENT TO, INTERIORIZATION AND FATE WITHIN MACROPHAGES
    DANFORTH, HD
    AIKAWA, M
    COCHRANE, AH
    NUSSENZWEIG, RS
    [J]. JOURNAL OF PROTOZOOLOGY, 1980, 27 (02): : 193 - 202
  • [10] DEGROOT AS, 1989, J IMMUNOL, V142, P4000